Literature DB >> 10918475

Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids.

N Krauzewicz1, C Cox, E Soeda, B Clark, S Rayner, B E Griffin.   

Abstract

Properties of a virus-like artificial gene delivery vehicle, synthesised from recombinant major coat protein of mouse polyoma virus, have been explored. The protein, VP1, self assembles into protein spheres, or 'pseudocapsids, which can bind and transfer DNA into cells in vitro and in vivo. Here, the ability of pseudocapsids to carry DNA into a complex cell system (ex vivo organ cultures of rabbit cornea) or whole animals (mice) has been assessed. Evidence from histochemical and PCR experiments indicate that pseudocapsids stimulate uptake and stable maintenance of marker DNA in nondividing corneal cells as efficiently as a recombinant adenovirus. In athymic and immunocompetent mice, gene transmission occurs with no apparent adverse effects on the animals. In the presence of pseudocapsids, the marker gene was transferred to a range of organs, including the brains of animals, following peripheral or intranasal administration. In immunocompetent mice, significant long-term transcriptional expression (at least 22 weeks) was observed with pseudocapsids, a period significantly longer than observed with DNA alone (several weeks only), again with no obvious adverse effects. This study demonstrates that pseudocapsids from the murine virus, polyoma, constitute a novel transfer agent for long-term gene therapeutic applications in tissues or whole animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918475     DOI: 10.1038/sj.gt.3301219

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

1.  Coupling of antibodies via protein Z on modified polyoma virus-like particles.

Authors:  S Gleiter; H Lilie
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

2.  Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus.

Authors:  S Heidari; N Krauzewicz; M Kalantari; A Vlastos; B E Griffin; T Dalianis
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles.

Authors:  K Stubenrauch; S Gleiter; U Brinkmann; R Rudolph; H Lilie
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

4.  Scanning surface confocal microscopy for simultaneous topographical and fluorescence imaging: application to single virus-like particle entry into a cell.

Authors:  J Gorelik; A Shevchuk; M Ramalho; M Elliott; C Lei; C F Higgins; Max J Lab; D Klenerman; N Krauzewicz; Y Korchev
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-04       Impact factor: 11.205

Review 5.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

6.  High-level gene transfer to the cornea using electroporation.

Authors:  Kathleen Blair-Parks; Bonnie C Weston; David A Dean
Journal:  J Gene Med       Date:  2002 Jan-Feb       Impact factor: 4.565

7.  Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.

Authors:  Tatyana Voronkova; Andris Kazaks; Velta Ose; Muhsin Ozel; Siegfried Scherneck; Paul Pumpens; Rainer Ulrich
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

8.  Imaging single virus particles on the surface of cell membranes by high-resolution scanning surface confocal microscopy.

Authors:  Andrew I Shevchuk; Phil Hobson; Max J Lab; David Klenerman; Nina Krauzewicz; Yuri E Korchev
Journal:  Biophys J       Date:  2008-01-16       Impact factor: 4.033

Review 9.  Improvement of different vaccine delivery systems for cancer therapy.

Authors:  Azam Bolhassani; Shima Safaiyan; Sima Rafati
Journal:  Mol Cancer       Date:  2011-01-07       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.